
  
    
      
        Background_NNP
        Malignant_NNP tumor_NN cells_NNS frequently_RB show_VBP deregulation_NN and_CC
        hyperactivation_NN of_IN signalling_VBG pathways_NNS ,_, one_CD of_IN which_WDT is_VBZ
        represented_VBN by_IN the_DT TGFβ_NNP signal_NN transduction_NN pathway_NN [_NN 1_CD ]_NN ._.
        TGFβ_NNP has_VBZ been_VBN shown_VBN to_TO potently_RB inhibit_VB proliferation_NN of_IN
        most_JJS epithelial_NN ,_, endothelial_NN and_CC hematopoietic_JJ cells_NNS [_NN 2_CD ]_NN
        ._. However_RB ,_, during_IN tumor_NN progression_NN malignant_JJ cells_NNS may_MD
        become_VB refractory_JJ to_TO TGFβ-mediated_NNP cell_NN cycle_NN arrest_NN ._. In_IN
        later_JJ stages_VBZ of_IN tumorigenesis_NNS ,_, TGFβ_NNP can_MD act_VB as_IN a_DT stimulator_NN
        of_IN invasion_NN and_CC metastasis_NNS [_NN 3_CD ]_NN acting_VBG directly_RB on_IN the_DT
        tumor_NN cells_NNS or_CC inducing_VBG angiogenesis_NNS and_CC facilitating_VBG local_JJ
        and_CC systemic_JJ immunosuppression_NN ,_, respectively_RB [_NN 4_CD ]_NN ._. For_IN
        example_NN ,_, TGFβ_NNP may_MD stimulate_VB the_DT expression_NN of_IN proteases_NNS
        such_JJ as_IN uPA_NN ,_, MMP-_NNP 3_CD or_CC MMP-_NNP 9_CD ,_, enzymes_NNS frequently_RB
        overexpressed_JJ in_IN invasive_JJ tumor_NN cells_NNS [_NN 5_CD 6_CD ]_NN ._.
        TGFβ_NNP signals_NNS through_IN a_DT heteromeric_JJ receptor_NN complex_NN of_IN
        type_NN II_NNP and_CC type_NN I_PRP receptor_NN serine-threonine_JJ kinases_NNS ,_, which_WDT
        activates_NNS the_DT downstream_JJ Smad_NNP signal_NN transduction_NN pathway_NN [_NN
        7_CD ]_NN ._. After_IN TGFβ_NNP binding_VBG to_TO the_DT receptor_NN complex_JJ ,_, the_DT TGFβ_NNP
        type_NN II_NNP receptor_NN kinase_NN phosphorylates_NNS TGFβ_NNP type_NN I_PRP receptor_NN
        which_WDT inititates_NNS the_DT downstream_JJ response_NN by_IN phosphorylating_VBG
        receptor-regulated_JJ Smads_NNP (_( R-S_NNP mads_NNS )_) ,_, such_JJ as_IN Smad_NNP 2_CD and_CC
        Smad_NNP 3_CD ._. By_IN forming_VBG a_DT multimeric_JJ complex_NN with_IN the_DT Co-_NNP Smad_NNP
        Smad_NNP 4_CD ,_, activated_VBN R-S_NNP mads_NNS translocate_NN to_TO the_DT nucleus_NN and_CC
        induce_VB transcriptional_NN modulation_NN of_IN target_NN genes_NNS [_NN 8_CD ]_NN
        ._.
        Breast_NNP cancer_NN cells_NNS frequently_RB metastasize_NN to_TO bone_NN
        causing_VBG bone_NN destruction_NN and_CC hypercalcemia_NN [_NN 9_CD ]_NN ._.
        Parathyroid_NNP hormone-related_JJ protein_NN (_( PTHrP_NNP )_) ,_, secreted_JJ by_IN
        these_DT cells_NNS ,_, is_VBZ a_DT major_JJ mediator_NN of_IN the_DT osteolytic_JJ process_NN
        [_NN 10_CD ]_NN ._. Osteolysis_NNP leads_VBZ to_TO the_DT release_NN of_IN TGFβ_NNP which_WDT ,_, in_IN
        turn_NN ,_, further_JJ induces_VBZ PTHrP_NNP expression_NN [_NN 11_CD ]_NN ._. Other_JJ
        tumor-relevant_JJ genes_NNS ,_, such_JJ as_IN 
        pai-_NN 1_CD or_CC 
        upa_NN ,_, can_MD also_RB be_VB activated_VBN by_IN
        TGFβ_NNP ._.
        Hence_RB ,_, downregulation_NN of_IN TGFβ_NNP mediated_JJ gene_NN expression_NN
        may_MD counteract_VB malignancy_NN of_IN cancer_NN cells_NNS ._. In_IN this_DT study_NN ,_,
        we_PRP investigated_VBD whether_IN two_CD small_JJ molecules_NNS ,_, SB-_NNP 203580_CD and_CC
        SB-_NNP 202190_CD ,_, could_MD be_VB used_VBN to_TO downmodulate_NN TGFβ-induced_NNP
        transcriptional_NN activation_NN of_IN TGFβ_NNP target_NN genes_NNS ._. In_IN the_DT
        past_NN ,_, these_DT compounds_NNS have_VBP been_VBN widely_RB used_VBN as_IN specific_JJ p_NN 38_CD
        inhibitors_NNS [_NN 12_CD ]_NN and_CC their_PRP$ inhibitory_NN action_NN has_VBZ been_VBN well_RB
        documented_VBN [_NN 13_CD 14_CD 15_CD ]_NN ._. However_RB ,_, recent_JJ results_NNS show_VBP
        that_IN ,_, in_IN a_DT comparable_JJ concentration_NN range_NN they_PRP inhibit_VBP the_DT
        serine_NN /_NN threonine_NN kinase_NN activity_NN of_IN TGFβ_NNP type_NN I_PRP receptor_NN
        preventing_VBG phosphorylation_NN of_IN R-S_NNP mads_NNS [_NN 16_CD 17_CD 18_CD ]_NN ._.
        Here_RB we_PRP show_VBP that_IN ,_, in_IN the_DT highly_RB invasive_JJ breast_NN cancer_NN
        cell_NN line_NN MDA-MB-_NNP 231_CD ,_, the_DT SB-_NNP 202190_CD and_CC SB-_NNP 203580_CD
        inhibitors_NNS negatively_RB altered_VBN Smad_NNP 3_CD nuclear_JJ entry_NN upon_IN TGFβ_NNP
        stimulation_NN ._. This_DT resulted_VBD in_IN a_DT reduced_VBN response_NN of_IN
        TGFβ-inducible_NNP genes_NNS to_TO TGFβ_NNP ._. The_DT degree_NN of_IN inhibition_NN
        varied_VBD tremendously_RB depending_VBG on_IN the_DT particular_JJ gene_NN
        analyzed_VBD ._.
      
      
        Results_NNS
        
          SB-_NNP 202190_CD and_CC SB-_NNP 203580_CD downregulate_NN transcription_NN
          from_IN TGFβ-responsive_NNP genes_NNS
          Plasminogen_NNP activator_NN inhibitor-_NN 1_CD (_( PAI-_NNP 1_LS )_) and_CC PTHrP_NNP
          are_VBP known_VBN target_NN genes_NNS of_IN TGFβ_NNP signalling_VBG ._. We_PRP have_VBP
          previously_RB demonstrated_VBN that_IN TGFβ_NNP upregulates_NNS PTHrP_NNP and_CC
          PAI-_NNP 1_CD RNA_NNP levels_NNS in_IN MDA-MB-_NNP 231_CD cells_NNS [_NN 19_CD ]_NN ._. TGFβ_NNP
          affected_VBD PTHrP_NNP expression_NN primarily_RB by_IN increasing_VBG the_DT
          level_NN of_IN the_DT promoter_NN P_NN 3_CD -_: specific_JJ transcript_NN [_NN 19_CD ]_NN ._.
          Quantitative_NNP PCR_NNP analysis_NN using_VBG primers_NNS allowing_VBG the_DT
          detection_NN of_IN PTHrP_NNP P_NN 3_CD and_CC PAI-_NNP 1_CD transcripts_NNS indicated_VBD
          that_DT incubation_NN of_IN MDA-MB-_NNP 231_CD cells_NNS with_IN SB-_NNP 202190_CD and_CC
          SB-_NNP 203580_CD greatly_RB inhibited_VBD TGFβ-induced_NNP increase_NN in_IN
          PTHrP_NNP and_CC ,_, to_TO a_DT lesser_JJR extent_NN ,_, PAI-_NNP 1_CD mRNA_NN levels_NNS (_( Fig_NNP ._.
          1_LS A_DT ,_, 1_CD B_NNP )_) ._.
          Next_JJ ,_, we_PRP examined_VBD whether_IN inhibitory_NN effects_NNS of_IN these_DT
          compounds_NNS can_MD also_RB be_VB seen_VBN on_IN the_DT PAI-_NNP 1_CD promoter_NN in_IN
          transient_JJ transfection_NN assays_NNS ._. By_IN using_VBG 3_CD TP-Luc_NNP as_IN a_DT
          reporter_NN plasmid_NN we_PRP observed_VBD that_IN TGFβ_NNP increased_VBD the_DT
          activity_NN of_IN 3_CD TP-Luc_NNP by_IN approximately_RB 3_CD ._. 5_CD -_: fold_VB (_( Fig_NNP ._.
          1_LS C_NNP ,_, 1_CD D_NNP )_) ._. Preincubation_NNP with_IN the_DT SB_NNP inhibitors_NNS reduced_VBD this_DT
          activation_NN almost_RB to_TO basal_NN levels_NNS ._.
          These_DT data_NNS suggest_VBP that_IN SB-_NNP 202190_CD and_CC SB-_NNP 203580_CD
          inhibit_VB TGFβ-stimulated_NNP gene_NN expression_NN at_IN least_JJS in_IN part_NN
          by_IN downregulating_VBG transcription_NN ._.
        
        
          SB-_NNP 202190_CD and_CC SB-_NNP 203580_CD deregulate_VB TGFβ-induced_NNP
          Smad_NNP 3_CD nuclear_JJ accumulation_NN
          It_PRP has_VBZ recently_RB been_VBN shown_VBN that_IN SB-_NNP 202190_CD and_CC
          SB-_NNP 203580_CD are_VBP able_JJ to_TO inhibit_VB TGFβ-induced_NNP
          phosphorylation_NN of_IN Smad_NNP 3_CD by_IN the_DT TGFβ-receptor_NNP I_PRP kinase_NN
          (_( ALK_NNP 5_LS )_) and_CC to_TO interfere_VB with_IN nuclear_JJ localization_NN of_IN
          Smad_NNP 3_CD [_NN 17_CD ]_NN ._. Nuclear_NNP translocation_NN of_IN Smad_NNP 3_CD results_NNS
          directly_RB from_IN TGFβ-induced_NNP Smad_NNP 3_CD phosphorylation_NN and_CC is_VBZ ,_,
          therefore_RB ,_, a_DT measure_NN of_IN the_DT activation_NN status_NN of_IN ALK_NNP 5_CD ._. We_PRP
          wanted_VBD to_TO know_VB to_TO what_WP extent_NN SB-_NNP 202190_CD and_CC SB-_NNP 203580_CD
          interfere_VB with_IN TGFβ-dependent_NNP Smad_NNP 3_CD nuclear_JJ import_NN in_IN the_DT
          invasive_JJ MDA-MB-_NNP 231_CD breast_NN cancer_NN cell_NN line_NN ._. We_PRP prepared_VBD
          nuclear_JJ and_CC whole_JJ cell_NN extracts_NNS from_IN cells_NNS treated_VBN with_IN
          TGFβ_NNP with_IN or_CC without_IN preincubation_NN of_IN one_CD of_IN the_DT SB_NNP
          inhibitors_NNS and_CC analyzed_VBD those_DT extracts_NNS for_IN reactivity_NN to_TO
          a_DT Smad_NNP 2_CD ,_, 3_CD -_: specific_JJ antibody_NN by_IN Western_JJ blot_NN analysis_NN ._.
          This_DT antibody_NN primarily_RB interacts_NNS with_IN Smad_NNP 3_CD ,_, but_CC ,_, to_TO
          some_DT extent_NN ,_, it_PRP is_VBZ also_RB able_JJ to_TO recognize_VB Smad_NNP 2_CD ._. Based_VBN on_IN
          Northern_NNP blot_NN hybridization_NN data_NNS ,_, Smad_NNP 3_CD ,_, but_CC not_RB Smad_NNP 2_CD ,_,
          is_VBZ expressed_VBN in_IN MDA-MB-_NNP 231_CD cells_NNS [_NN 21_CD ]_NN ._. Hence_RB ,_, the_DT data_NNS
          presented_VBN in_IN Fig_NNP ._. 2_LS show_NN the_DT abundance_NN of_IN Smad_NNP 3_CD in_IN the_DT
          nuclear_JJ and_CC in_IN the_DT whole_JJ cell_NN extracts_NNS ._. We_PRP found_VBD that_DT
          preincubation_NN of_IN cells_NNS with_IN either_DT SB-_NNP 202190_CD or_CC SB-_NNP 203580_CD
          decreased_VBD the_DT level_NN of_IN nuclear_JJ Smad_NNP 3_CD in_IN the_DT presence_NN of_IN
          TGFβ_NNP (_( Fig_NNP ._. 2_LS A_DT )_) ,_, whereas_IN the_DT total_JJ Smad_NNP 3_CD protein_NN level_NN ,_, as_IN
          assayed_JJ in_IN whole_JJ cell_NN extracts_NNS ,_, was_VBD not_RB altered_VBN ._.
          Next_JJ ,_, we_PRP studied_VBD the_DT time-course_JJ of_IN TGFβ-induced_NNP Smad_NNP 3_CD
          nuclear_JJ entry_NN in_IN the_DT presence_NN or_CC absence_NN of_IN SB-_NNP 203580_CD ._.
          MDA-MB-_NNP 231_CD cells_NNS were_VBD stimulated_VBN with_IN TGFβ_NNP and_CC harvested_VBN
          after_IN various_JJ time_NN points_NNS ._. Nuclear_JJ extracts_NNS were_VBD prepared_VBN
          and_CC subjected_VBN to_TO Western_NNP blotting_VBG analysis_NN using_VBG an_DT
          anti-_NN Smad_NNP 3_CD antibody_NN ._. Stimulation_NNP of_IN the_DT cells_NNS with_IN TGFβ_NNP
          led_VBD to_TO a_DT rapid_JJ increase_NN in_IN nuclear_JJ Smad_NNP 3_CD protein_NN within_IN
          15_CD minutes_NNS and_CC this_DT level_NN remained_VBD constant_JJ for_IN 2_CD hours_NNS ._.
          Thereafter_RB it_PRP started_VBD to_TO decrease_VB ._. However_RB ,_, pretreatment_NN
          of_IN the_DT cells_NNS with_IN 20_CD μM_NN SB-_NNP 203580_CD perturbed_VBD Smad_NNP 3_CD nuclear_JJ
          accumulation_NN ,_, reducing_VBG the_DT amount_NN of_IN Smad_NNP 3_CD entering_VBG the_DT
          nucleus_NN and_CC shifting_VBG the_DT peak_NN level_NN of_IN nuclear_JJ Smad_NNP 3_CD to_TO a_DT
          later_JJ time_NN point_NN ._.
        
        
          Other_JJ kinase_NN inhibitors_NNS fail_VBP to_TO inhibit_VB TGFβ_NNP
          mediated_JJ Smad_NNP 3_CD nuclear_JJ entry_NN
          We_PRP next_JJ explored_JJ the_DT possibility_NN that_IN the_DT MEK_NNP 1_CD /_NN 2_CD
          inhibitor_NN PD_NNP 98059_CD and_CC the_DT Rho-associated_NNP kinase_NN inhibitor_NN
          Y-_NNP 27632_CD might_MD also_RB interfere_VB with_IN Smad_NNP 3_CD nuclear_JJ entry_NN ._.
          However_RB ,_, both_DT agents_NNS failed_VBD to_TO reproduce_VB the_DT effect_NN of_IN
          the_DT SB_NNP inhibitors_NNS as_IN TGFβ-induced_NNP nuclear_JJ accumulation_NN of_IN
          Smad_NNP 3_CD was_VBD not_RB affected_VBN by_IN these_DT inhibitors_NNS (_( Fig_NNP ._. 2_LS C_NNP )_) ._. We_PRP
          also_RB used_VBD the_DT protein_NN kinase_NN C_NNP (_( PKC_NNP )_) activator_NN
          phorbol-_NN 12_CD -_: myristate-_NN 13_CD -_: acetate_NN (_( PMA_NNP )_) (_( Fig_NNP ._. 2_LS C_NNP )_) ,_, which_WDT
          appeared_VBD to_TO enhance_VB the_DT amount_NN of_IN both_DT basal_NN and_CC
          TGFβ-induced_NNP nuclear_JJ Smad_NNP 3_CD ,_, a_DT phenomenon_NN that_WDT has_VBZ been_VBN
          reported_VBN earlier_JJR [_NN 22_CD ]_NN ._.
        
        
          TGFβ_NNP target_NN genes_NNS respond_VBP differentially_RB to_TO
          inhibition_NN of_IN Smad_NNP 3_CD nuclear_JJ import_NN
          The_DT delayed_VBN TGFβ-mediated_NNP entry_NN of_IN Smad_NNP 3_CD into_IN the_DT
          nucleus_NN in_IN the_DT presence_NN of_IN SB-_NNP 203580_CD prompted_VBD us_PRP to_TO
          examine_VB the_DT effect_NN of_IN SB-_NNP 203580_CD on_IN TGFβ-induced_NNP gene_NN
          expression_NN in_IN a_DT time-course_JJ experiment_NN ._. We_PRP isolated_VBD total_JJ
          RNA_NNP from_IN the_DT same_JJ cell_NN suspension_NN that_WDT was_VBD used_VBN to_TO
          prepare_VB nuclear_JJ extracts_NNS for_IN time-course_JJ analysis_NN in_IN Fig_NNP ._.
          2_LS B_NNP ._. cDNA_NN was_VBD synthesized_JJ and_CC subjected_VBN to_TO quantitative_JJ
          RT-PCR_NNP in_IN order_NN to_TO measure_VB the_DT transcript_NN levels_NNS of_IN
          several_JJ TGFβ_NNP target_NN genes_NNS ._. The_DT genes_NNS being_VBG examined_VBN were_VBD
          divided_VBN into_IN two_CD groups_NNS :_: I_PRP ,_, known_VBN TGFβ_NNP target_NN genes_NNS :_: 
          pai-_NN 1_CD ,_, smad_NN 7_CD ,_, c-myc_JJ ,_, upa_NN and_CC
          pthrp_NN (_( Fig_NNP ._. 3_LS A_DT ,_, 3_CD B_NNP ,_, 3_CD C_NNP ,_, 3_CD D_NNP ,_, 3_CD E_NNP )_) and_CC II_NNP ,_, ets_NNS family_NN genes_NNS :_:
          
          ets-_NN 1_CD ,_, ets-_NN 2_CD and_CC ese-_NN 1_CD /_NN esx_NN ._. Smad_NNP 7_CD
          was_VBD of_IN particular_JJ interest_NN as_IN it_PRP belongs_VBZ to_TO the_DT
          inhibitory_NN Smads_NNP ,_, which_WDT can_MD counteract_VB TGFβ-induced_NNP gene_NN
          activation_NN [_NN 23_CD ]_NN ._. The_DT response_NN of_IN the_DT 
          smad_NN 7_CD gene_NN to_TO TGFβ_NNP is_VBZ unusually_RB
          rapid_JJ [_NN 24_CD ]_NN which_WDT is_VBZ believed_VBN to_TO stem_VB from_IN the_DT peculiar_JJ
          nature_NN of_IN the_DT Smad_NNP 7_CD promoter_NN that_WDT contains_VBZ a_DT "_'' perfect_JJ "_''
          Smad_NNP binding_JJ site_NN [_NN 25_CD ]_NN ._. Another_DT inhibitory_NN Smad_NNP
          protein_NN is_VBZ Smad_NNP 6_CD ._. We_PRP have_VBP not_RB analyzed_VBN the_DT expression_NN of_IN
          this_DT protein_NN ,_, since_IN it_PRP preferentially_RB inhibit_VBP bone_NN
          morphogenetic_JJ protein_NN (_( BMP_NN )_) -_: induced_VBN expression_NN [_NN 26_CD ]_NN ._.
          In_IN addition_NN ,_, Smad_NNP 6_CD shows_VBZ varying_VBG effects_NNS on_IN TGFβ_NNP
          signalling_VBG [_NN 27_CD ]_NN ._. Nor_CC were_VBD TGFβ-responsive_NNP genes_NNS ,_, such_JJ
          as_IN p_NN 21_CD ,_, studied_VBN that_WDT are_VBP involved_VBN in_IN cell_NN cycle_NN
          regulation_NN ._. Such_JJ genes_NNS are_VBP important_JJ targets_NNS at_IN
          early-stage_JJ carcinogenesis_NNS ,_, where_WRB TGFβ_NNP has_VBZ a_DT
          tumor-suppressive_JJ rather_RB than_IN a_DT tumor-promoting_JJ function_NN
          [_NN 28_CD ]_NN ._. In_IN addition_NN ,_, e_SYM ._. g_SYM ._. p_NN 21_CD protein_NN is_VBZ not_RB dectable_JJ in_IN
          MDA-MB-_NNP 231_CD cells_NNS [_NN 29_CD ]_NN ._.
          Of_IN group_NN I_PRP ,_, 
          pai-_NN 1_CD ,_, 
          pthrp_NN and_CC 
          upa_NN mRNAs_NNS were_VBD induced_VBN upon_IN TGFβ_NNP
          treatment_NN reaching_VBG maximum_NN activation_NN within_IN three_CD hours_NNS ._.
          As_IN expected_VBN ,_, the_DT 
          smad_NN 7_CD transcript_NN was_VBD fully_RB
          upregulated_JJ much_JJ earlier_RBR ,_, after_IN approximately_RB 60_CD min_NN ._. The_DT
          
          c-myc_JJ gene_NN has_VBZ been_VBN reported_VBN to_TO be_VB
          unresponsive_JJ to_TO TGFβ_NNP signal_NN transduction_NN in_IN MDA-MB-_NNP 231_CD
          cells_NNS [_NN 24_CD ]_NN ._. We_PRP also_RB measured_VBD the_DT effect_NN of_IN TGFβ_NNP on_IN 
          c-myc_JJ RNA_NNP and_CC confirmed_VBD these_DT
          results_NNS as_IN SB-_NNP 203580_CD or_CC control_NN treatment_NN failed_VBD to_TO
          significantly_RB modulate_VBP 
          c-myc_JJ transcript_NN levels_NNS ._. The_DT
          inhibitory_NN effect_NN of_IN SB-_NNP 203580_CD showed_VBD remarkable_JJ
          variation_NN among_IN the_DT genes_NNS examined_VBD ._. The_DT rapid_JJ induction_NN
          of_IN 
          smad_NN 7_CD mRNA_NN was_VBD basically_RB unaffected_JJ
          by_IN SB-_NNP 203580_CD ;_: this_DT could_MD possibly_RB explained_VBN by_IN a_DT lower_JJR
          amout_NN of_IN Smad_NNP 3_CD necessary_JJ to_TO activate_VBP the_DT Smad_NNP 7_CD promoter_NN ._.
          TGFβ_NNP induced_VBD 
          pai-_NN 1_CD mRNA_NN was_VBD reduced_VBN to_TO
          approximately_RB 50_CD %_NN by_IN the_DT SB_NNP inhibitor_NN ,_, whereas_IN
          TGFβ-mediated_NNP expression_NN of_IN PTHrP_NNP and_CC uPA_NN was_VBD highly_RB
          sensitive_JJ to_TO SB-_NNP 203580_CD treatment_NN ._. SB-_NNP 203580_CD downmodulated_JJ
          expression_NN of_IN the_DT latter_JJ genes_NNS to_TO almost_RB basal_NN levels_NNS ._.
          Two_CD 
          ets_NNS genes_NNS ,_, 
          ets_NNS 1_CD and_CC 
          ets_NNS 2_CD ,_, were_VBD also_RB affected_VBN by_IN TGFβ_NNP
          and_CC SB-_NNP 203580_CD (_( Group_NNP II_NNP ,_, Fig_NNP ._. 3_LS F_NN ,_, 3_CD G_NNP )_) ._. We_PRP observed_VBD that_IN 
          ets_NNS 1_CD and_CC 
          ets_NNS 2_CD transcript_NN levels_NNS were_VBD
          slightly_RB upregulated_JJ when_WRB cells_NNS were_VBD incubated_JJ with_IN TGFβ_NNP
          and_CC that_IN this_DT increase_NN was_VBD partly_RB inhibited_VBD by_IN SB-_NNP 203580_CD ._.
          The_DT other_JJ 
          ets_NNS gene_NN that_IN we_PRP tested_VBD was_VBD 
          ese-_NN 1_CD /_NN esx_NN ,_, a_DT recently_RB
          characterized_VBN member_NN of_IN the_DT 
          ets_NNS gene_NN family_NN ,_, originally_RB
          identified_VBN in_IN epithelial_NN cells_NNS [_NN 30_CD ]_NN ._. Ese-_NNP 1_CD /_NN Esx_NNP has_VBZ
          been_VBN found_VBN to_TO regulate_VB the_DT expression_NN of_IN TGFβ_NNP type_NN II_NNP
          receptor_NN [_NN 31_CD ]_NN ._. We_PRP could_MD show_VB for_IN the_DT first_JJ time_NN that_IN
          the_DT level_NN of_IN the_DT Ese-_NNP 1_CD /_NN Esx_NNP transcript_NN was_VBD strongly_RB
          downregulated_JJ in_IN the_DT presence_NN of_IN TGFβ_NNP ._. The_DT negative_JJ TGFβ_NNP
          effect_NN on_IN Ese-_NNP 1_CD /_NN Esx_NNP expression_NN could_MD not_RB be_VB inhibited_VBD by_IN
          SB-_NNP 203580_CD ._.
        
      
      
        Discussion_NNP
        Evidence_NN has_VBZ been_VBN accumulated_VBN that_IN TGFβ_NNP promotes_VBZ
        late-stage_JJ tumorigenesis_NNS by_IN stimulating_VBG angiogenesis_NNS and_CC
        invasive_JJ behaviour_NN of_IN tumor_NN cells_NNS ,_, enhancing_VBG
        immunosuppression_NN and_CC supporting_VBG epithelial-mesenchymal_JJ
        transition_NN of_IN cancer_NN cells_NNS [_NN 4_CD ]_NN ._. Furthermore_RB ,_, TGFβ_NNP is_VBZ
        believed_VBN to_TO be_VB part_NN of_IN a_DT vicious_JJ circle_NN in_IN bone_NN metastases_NNS
        as_IN it_PRP gets_VBZ released_VBN from_IN osteoclast-degraded_JJ bone_NN substance_NN
        and_CC subsequently_RB stimulates_NNS PTHrP_NNP gene_NN expression_NN in_IN nearby_JJ
        metastatic_JJ cancer_NN cells_NNS which_WDT in_IN turn_NN leads_VBZ to_TO an_DT
        activation_NN of_IN osteoclastic_JJ bone_NN resorption_NN [_NN 11_CD ]_NN ._.
        Therefore_RB ,_, it_PRP is_VBZ of_IN great_JJ interest_NN to_TO understand_VB in_IN more_JJR
        detail_NN the_DT molecular_JJ aspects_NNS of_IN TGFβ-mediated_NNP gene_NN
        expression_NN in_IN metastatic_JJ breast_NN cancer_NN cells_NNS and_CC to_TO explore_VB
        ways_NNS to_TO interfere_VB with_IN this_DT tumorigenic_JJ signalling_VBG ._.
        Here_RB we_PRP report_VBP that_IN two_CD small_JJ molecules_NNS ,_, SB-_NNP 202190_CD and_CC
        SB-_NNP 203580_CD ,_, diminished_VBD TGFβ-induced_NNP expression_NN of_IN TGFβ_NNP
        target_NN genes_NNS which_WDT was_VBD accompanied_VBN by_IN a_DT perturbation_NN of_IN
        TGFβ-mediated_NNP Smad_NNP 3_CD nuclear_JJ accumulation_NN ,_, a_DT crucial_JJ step_NN in_IN
        TGFβ_NNP signal_NN transduction_NN ._. Using_VBG SB-_NNP 203580_CD ,_, we_PRP found_VBD that_IN
        not_RB only_RB was_VBD the_DT total_JJ level_NN of_IN nuclear_JJ Smad_NNP 3_CD in_IN the_DT
        presence_NN of_IN TGFβ_NNP reduced_VBD ,_, but_CC also_RB that_IN the_DT nuclear_JJ entry_NN
        of_IN Smad_NNP 3_CD was_VBD delayed_VBN and_CC less_RBR prolonged_JJ ._. Interestingly_RB ,_,
        treating_VBG cells_NNS with_IN TGFβ_NNP for_IN 60_CD min_NN yielded_VBD a_DT similar_JJ
        amount_NN of_IN Smad_NNP 3_CD in_IN the_DT nucleus_NN ,_, irrespective_RB of_IN whether_IN
        SB-_NNP 203580_CD was_VBD present_JJ or_CC not_RB ._. However_RB ,_, when_WRB the_DT time_NN of_IN
        TGFβ_NNP treatment_NN was_VBD reduced_VBN to_TO 15_CD min_NN or_CC prolonged_VBN to_TO 180_CD or_CC
        240_CD min_NN ,_, SB-_NNP 203580_CD had_VBD a_DT tremendous_JJ effect_NN on_IN Smad_NNP 3_CD
        translocation_NN to_TO the_DT nucleus_NN ._. The_DT altered_VBN kinetic_JJ of_IN
        TGFβ-dependent_NNP Smad_NNP 3_CD nuclear_JJ entry_NN as_IN induced_VBN by_IN SB-_NNP 203580_CD
        coincided_VBD with_IN the_DT efficacy_NN by_IN which_WDT this_DT agent_NN repressed_JJ
        the_DT activity_NN of_IN the_DT different_JJ TGFβ_NNP target_NN genes_NNS ._. Fast_NNP TGFβ_NNP
        responder_NN genes_NNS ,_, such_JJ as_IN 
        smad_NN 7_CD ,_, whose_WP$ maximum_NN activation_NN by_IN
        TGFβ_NNP was_VBD reached_VBN after_IN 60_CD min_NN ,_, was_VBD only_RB slightly_RB affected_VBN
        by_IN SB-_NNP 203580_CD ,_, while_IN slow_JJ responders_NNS ,_, such_JJ as_IN 
        pai-_NN 1_CD ,_, pthrp_NN or_CC 
        upa_NN ,_, that_WDT showed_VBD peak_NN activation_NN
        after_IN 180_CD -_: 240_CD min_NN ,_, were_VBD very_RB sensitive_JJ to_TO the_DT repressive_JJ
        effect_NN of_IN SB-_NNP 203580_CD ._. The_DT strongest_JJS effect_NN of_IN SB-_NNP 203580_CD was_VBD
        found_VBN on_IN the_DT TGFβ-dependent_NNP expression_NN of_IN 
        pthrp_NN and_CC 
        upa_NN ._. In_IN these_DT cases_NNS ,_, the_DT inhibitor_NN
        completely_RB eliminated_VBD responsiveness_NNS to_TO TGFβ_NNP ._.
        How_WRB could_MD these_DT differential_NN effect_NN of_IN SB-_NNP 203580_CD on_IN
        TGFβ-induced_NNP gene_NN expression_NN be_VB explained_VBN ?_. It_PRP is_VBZ clear_JJ that_IN
        the_DT 
        smad_NN 7_CD gene_NN expression_NN is_VBZ regulated_VBN by_IN
        TGFβ_NNP in_IN a_DT Smad_NNP 3_CD /_NN 4_CD -_: dependent_JJ manner_NN [_NN 32_CD ]_NN as_IN it_PRP was_VBD found_VBN
        for_IN the_DT 
        pthrp_NN and_CC the_DT 
        pai-_NN 1_CD gene_NN [_NN 19_CD 33_CD ]_NN ._. However_RB ,_, the_DT
        Smad_NNP 3_CD responsive_JJ elements_NNS are_VBP different_JJ ._. The_DT 
        smad_NN 7_CD gene_NN contains_VBZ a_DT perfect_JJ
        palindromic_JJ Smad_NNP binding_JJ element_NN (_( GTCTAGAC_NNP )_) while_IN the_DT 
        pai-_NN 1_CD and_CC the_DT 
        pthrp_NN promoters_NNS harbor_VBP AGAC_NNP tandem_JJ
        repeats_VBZ [_NN 19_CD 33_CD ]_NN which_WDT binds_NNS Smad_NNP proteins_NNS less_RBR
        efficiently_RB [_NN 34_CD ]_NN ._. The_DT 
        upa_NN gene_NN contains_VBZ only_RB an_DT AP_NNP 1_CD -_: binding_JJ
        site_NN which_WDT resembles_VBZ the_DT Smad_NNP 3_CD /_NN 4_CD -_: responsive_JJ AGAC_NNP motif_NN [_NN 35_CD
        ]_NN ._. A_DT weaker_JJR binding_JJ site_NN could_MD require_VB Smad_NNP 3_CD to_TO be_VB present_JJ
        at_IN higher_JJR concentrations_NNS for_IN efficient_JJ binding_JJ and_CC would_MD
        make_VB TGFβ-dependent_NNP transcription_NN from_IN a_DT gene_NN more_RBR
        vulnerable_JJ to_TO reduced_VBN nuclear_JJ accumulation_NN of_IN the_DT Smad_NNP 3_CD
        protein_NN ._. TGFβ-induced_NNP stabilization_NN of_IN the_DT mRNA_NN may_MD also_RB be_VB
        important_JJ for_IN the_DT sensitivity_NN to_TO SB-_NNP 203580_CD ._. TGFβ_NNP has_VBZ been_VBN
        shown_VBN also_RB to_TO stabilize_VB the_DT mRNA_NN of_IN the_DT 
        smad_NN 7_CD gene_NN [_NN 25_CD ]_NN ,_, while_IN
        stabilization_NN of_IN RNA_NNP does_VBZ not_RB play_VB a_DT major_JJ role_NN in_IN
        regulation_NN of_IN the_DT 
        pthrp_NN gene_NN in_IN MDA-MB-_NNP 231_CD cells_NNS [_NN 19_CD ]_NN
        ._. In_IN addition_NN ,_, SB-_NNP 203580_CD also_RB inhibits_NNS p_NN 38_CD activity_NN which_WDT
        has_VBZ been_VBN shown_VBN to_TO play_VB a_DT role_NN in_IN TGFβ_NNP signalling_VBG [_NN 36_CD 37_CD 38_CD
        39_CD 40_CD 41_CD ]_NN ._. Hence_RB ,_, several_JJ factors_NNS could_MD be_VB responsible_JJ
        for_IN the_DT differential_NN sensitivity_NN of_IN TGFβ-responsive_NNP genes_NNS
        to_TO SB-_NNP 203580_CD ._.
        Members_NNS of_IN the_DT Ets_NNP family_NN of_IN transcription_NN factors_NNS share_VBP
        a_DT unique_JJ DNA_NNP binding_JJ domain_NN ,_, the_DT Ets_NNP domain_NN ,_, and_CC have_VBP been_VBN
        shown_VBN to_TO activate_VBP a_DT large_JJ number_NN of_IN genes_NNS [_NN 42_CD 43_CD ]_NN and_CC to_TO
        be_VB involved_VBN in_IN a_DT number_NN of_IN physiological_JJ and_CC
        pathophysiological_JJ processes_VBZ [_NN 44_CD ]_NN ._. There_EX has_VBZ been_VBN
        accumulating_VBG evidence_NN that_IN Ets_NNP proteins_NNS play_VBP an_DT important_JJ
        part_NN for_IN the_DT invasive_JJ program_NN of_IN cells_NNS ,_, particularly_RB by_IN
        stimulating_VBG the_DT expression_NN of_IN protease_NN genes_NNS [_NN 45_CD 46_CD ]_NN ._.
        Ets_NNP 1_CD and_CC Ets_NNP 2_CD are_VBP overexpressed_JJ in_IN a_DT variety_NN of_IN tumors_NNS ,_,
        including_VBG breast_NN carcinomas_NNS (_( [_NN 44_CD ]_NN and_CC references_NNS
        therein_RB )_) ._. Furthermore_RB ,_, our_PRP$ previous_JJ work_NN has_VBZ shown_VBN that_IN ,_, in_IN
        invasive_JJ breast_NN cancer_NN cells_NNS ,_, Ets_NNP proteins_NNS activate_VBP the_DT
        PTHrP_NNP P_NN 3_CD promoter_NN in_IN cooperation_NN with_IN Smad_NNP 3_CD [_NN 19_CD ]_NN ._. In_IN
        this_DT context_NN it_PRP is_VBZ interesting_JJ to_TO note_VB that_IN TGFβ_NNP signalling_VBG
        seemed_VBN to_TO target_VB the_DT 
        ets-_NN 1_CD and_CC 
        ets-_NN 2_CD gene_NN (_( Fig_NNP ._. 3_LS F_NN ,_, 3_CD G_NNP )_) ._. Analysis_NNP of_IN
        the_DT human_JJ ets-_NN 1_CD promoter_NN sequence_NN revealed_VBD that_IN it_PRP contains_VBZ
        elements_NNS similar_JJ to_TO TGFβ-responsive_NNP sites_NNS in_IN other_JJ
        promoters_NNS (_( R_NN ._. Lindemann_NNP ,_, unpublished_JJ observation_NN )_) ._.
        We_PRP present_JJ data_NNS showing_VBG that_IN TGFβ_NNP downregulated_JJ the_DT
        Ese-_NNP 1_CD /_NN Esx_NNP transcript_NN ,_, a_DT novel_NN and_CC yet_RB unpublished_JJ finding_NN ._.
        Ese-_NNP 1_CD /_NN Esx_NNP is_VBZ a_DT member_NN of_IN the_DT Ets_NNP transcription_NN factor_NN
        family_NN and_CC is_VBZ expressed_VBN mainly_RB in_IN epithelial_NN tissue_NN [_NN 30_CD ]_NN
        ._. Its_PRP$ expression_NN has_VBZ been_VBN detected_VBN during_IN mammary_JJ gland_NN
        development_NN and_CC breast_NN tumorigenesis_NNS [_NN 47_CD 48_CD ]_NN ._. It_PRP is_VBZ
        noteworthy_JJ that_IN Ese-_NNP 1_CD /_NN Esx_NNP is_VBZ a_DT potential_JJ transcriptional_NN
        regulator_NN of_IN the_DT TGFβ_NNP type_NN II_NNP receptor_NN [_NN 31_CD ]_NN and_CC
        overexpression_NN of_IN Ese-_NNP 1_CD /_NN Esx_NNP in_IN non-invasive_JJ cells_NNS leads_VBZ to_TO
        a_DT reduction_NN in_IN cell_NN growth_NN in_IN the_DT presence_NN of_IN TGFβ_NNP ,_,
        presumably_RB because_IN of_IN an_DT increased_VBN TGFβ_NNP type_NN II_NNP receptor_NN
        level_NN [_NN 49_CD ]_NN ._. It_PRP is_VBZ interesting_JJ that_IN TGFβ-dependent_NNP
        downregulation_NN of_IN Ese-_NNP 1_CD /_NN Esx_NNP is_VBZ not_RB affected_VBN by_IN SB-_NNP 203580_CD ._.
        It_PRP is_VBZ possible_JJ that_IN TGFβ_NNP does_VBZ not_RB require_VB Smad_NNP 3_CD /_NN 4_CD or_CC p_NN 38_CD to_TO
        inhibit_VB Ese-_NNP 1_CD /_NN Esx-expression_NNP ._. Alternatively_RB ,_, inhibitory_NN
        Smad_NNP 7_CD ,_, whose_WP$ expression_NN was_VBD increased_VBN by_IN TGFβ_NNP but_CC not_RB
        affected_VBN by_IN SB-_NNP 203580_CD ,_, may_MD be_VB involved_VBN in_IN this_DT process_NN ._. One_CD
        way_NN by_IN which_WDT Smad_NNP 7_CD can_MD inhibit_VB TGFβ-dependent_NNP gene_NN
        expression_NN is_VBZ by_IN blocking_VBG phosphorylation_NN ,_, and_CC ,_, hence_RB ,_,
        nuclear_JJ import_NN of_IN Smad_NNP 3_CD and_CC Smad_NNP 2_CD [_NN 23_CD ]_NN ._. More_RBR recent_JJ data_NNS
        showing_VBG that_IN Smad_NNP 7_CD is_VBZ able_JJ to_TO interact_NN with_IN histone_NN
        deacetylases_NNS suggest_VBP an_DT additional_JJ role_NN for_IN Smad_NNP 7_CD as_IN a_DT
        transcriptional_NN co-repressor_JJ [_NN 50_CD ]_NN ._. Thus_RB ,_, Smad_NNP 7_CD might_MD
        interfere_VB directly_RB with_IN Ese-_NNP 1_CD /_NN Esx_NNP gene_NN transcription_NN ._.
        However_RB ,_, TGFβ_NNP downregulated_JJ Ese-_NNP 1_CD /_NN Esx_NNP mRNA_NN levels_NNS faster_RBR
        than_IN it_PRP upregulated_JJ Smad_NNP 7_CD expression_NN excluding_VBG the_DT
        possibility_NN that_IN Smad_NNP 7_CD mediates_NNS the_DT TGFβ_NNP effect_NN on_IN
        Ese-_NNP 1_CD /_NN Esx_NNP ,_, at_IN least_JJS at_IN the_DT initial_JJ phase_NN ._. Another_DT candidate_NN
        that_WDT could_MD be_VB responsible_JJ for_IN this_DT process_NN is_VBZ c-_NN Jun_NNP
        N-_NNP terminal_NN kinase_NN (_( JNK_NNP )_) ._. JNK_NNP has_VBZ been_VBN described_VBN to_TO drive_VB
        TGFβ-dependent_NNP fibronectin_NN synthesis_NN independent_JJ of_IN Smad_NNP 4_CD
        and_CC p_NN 38_CD [_NN 51_CD ]_NN ._. In_IN contrast_NN to_TO Smad_NNP 3_CD ,_, JNK_NNP is_VBZ activated_VBN by_IN
        the_DT TGFβ_NNP receptor_NN I_PRP in_IN a_DT way_NN that_WDT does_VBZ not_RB require_VB the_DT
        kinase_NN domain_NN [_NN 52_CD ]_NN ._. This_DT supports_VBZ the_DT notion_NN that_DT
        activation_NN of_IN Smad_NNP 3_CD and_CC JNK_NNP by_IN TGFβ_NNP are_VBP independent_JJ events_NNS ._.
        It_PRP is_VBZ remarkable_JJ that_IN a_DT constitutively_RB active_JJ form_NN of_IN JNK_NNP
        activator_NN MKK_NNP and_CC Smad_NNP 7_CD are_VBP able_JJ to_TO cooperatively_RB
        downregulate_NN TGFβ-responsive_NNP promoters_NNS [_NN 53_CD ]_NN ._. It_PRP is_VBZ quite_RB
        possible_JJ that_IN a_DT Smad_NNP 7_CD /_NN JNK_NNP synergistic_JJ interaction_NN is_VBZ
        involved_VBN in_IN the_DT TGFβ-dependent_NNP downregulation_NN of_IN Ese-_NNP 1_CD /_NN Esx_NNP
        expression_NN ,_, where_WRB JNK_NNP alone_RB might_MD mediate_VB the_DT initiation_NN of_IN
        the_DT TGFβ-induced_NNP repression_NN ._.
      
      
        Conclusions_NNP
        We_PRP demonstrate_VBP that_DT treatment_NN of_IN invasive_JJ MDA-MB-_NNP 231_CD
        breast_NN cancer_NN cells_NNS with_IN SB-_NNP 202190_CD and_CC SB-_NNP 203580_CD interferes_VBZ
        with_IN TGFβ-induced_NNP Smad_NNP 3_CD nuclear_JJ accumulation_NN and_CC that_IN this_DT
        is_VBZ paralleled_JJ by_IN a_DT differential_NN transcriptional_NN response_NN of_IN
        TGFβ_NNP target_NN genes_NNS ._. Strikingly_NNP ,_, SB-_NNP 202190_CD and_CC SB-_NNP 203580_CD
        suppressed_VBN TGFβ-dependent_NNP activation_NN of_IN those_DT genes_NNS that_WDT
        are_VBP important_JJ for_IN the_DT acquisition_NN of_IN invasive_JJ behavior_NN ,_,
        while_IN having_VBG no_DT effect_NN on_IN the_DT expression_NN of_IN the_DT natural_JJ
        TGFβ_NNP inhibitor_NN Smad_NNP 7_CD ._. This_DT suggests_VBZ that_IN these_DT compounds_NNS
        may_MD be_VB useful_JJ to_TO interfere_VB with_IN malignant_JJ behavior_NN of_IN
        cancer_NN cells_NNS ._. Furthermore_RB ,_, we_PRP show_VBP for_IN the_DT first_JJ time_NN that_IN ,_,
        in_IN breast_NN cancer_NN cells_NNS ,_, the_DT Ese-_NNP 1_CD /_NN Esx_NNP mRNA_NN is_VBZ downregulated_JJ
        by_IN TGFβ_NNP ._.
      
      
        Methods_NNP
        
          Cell_NNP lines_NNS ,_, plasmids_NNS and_CC chemicals_NNS
          MDA-MB-_NNP 231_CD breast_NN cancer_NN cell_NN line_NN was_VBD maintained_VBN in_IN
          Dulbecco_NNP 's_POS modified_VBN Eagle_NNP 's_POS medium_NN (_( Invitrogen_NNP )_)
          supplemented_JJ with_IN 10_CD %_NN fetal_JJ calf_NN serum_NN (_( Invitrogen_NNP )_) ._. The_DT
          plasmid_NN 3_CD TP-Luc_NNP was_VBD kindly_RB provided_VBN by_IN Y_NNP ._. Sun_NNP ._. TGFβ_NNP 1_CD was_VBD
          purchased_VBN from_IN R_NN &_CC D_NNP Systems_NNPS and_CC dissolved_VBN in_IN 1_CD mg_NN /_NN ml_NN
          bovine_JJ serum_NN albumine_NN in_IN 4_CD mM_NN HCl_NNP as_IN recommended_VBN by_IN the_DT
          manufacturer_NN ._. The_DT inhibitors_NNS PD-_NNP 98059_CD ,_, Y-_NNP 27632_CD ,_, SB-_NNP 202190_CD
          and_CC SB-_NNP 203580_CD were_VBD obtained_VBN from_IN Calbiochem_NNP and_CC dissolved_VBN
          in_IN dimethyl_NN sulfoxide_NN ._.
        
        
          Transient_NNP transfections_NNS and_CC luciferase_NN assay_NN
          Transient_NNP transfection_NN of_IN MDA-MB-_NNP 231_CD breast_NN cancer_NN
          cells_NNS has_VBZ been_VBN described_VBN previously_RB [_NN 19_CD ]_NN ._. Briefly_NNP ,_, 2_CD
          μg_NN 3_CD TP-Luc_NNP together_RB with_IN 0_CD ._. 3_CD μg_NN β-galactosidase_JJ
          expression_NN plasmid_NN were_VBD transfected_JJ into_IN cells_NNS grown_VBN to_TO
          70_CD -_: 80_CD %_NN confluency_NN in_IN 6_CD -_: well_RB plates_NNS using_VBG LipofectAMINE_NNP
          reagent_NN (_( Invitrogen_NNP )_) following_VBG the_DT manufacturers_NNS
          protocol_NN ._. TGFβ_NNP stimulation_NN of_IN cells_NNS (_( 5_CD ng_NN /_NN ml_NN )_) was_VBD
          performed_VBN 15_CD hours_NNS after_IN transfection_NN for_IN the_DT indicated_VBN
          times_NNS with_IN or_CC without_IN preincubation_NN with_IN the_DT respective_JJ
          inhibitors_NNS ._. Control_NN cells_NNS were_VBD treated_VBN with_IN the_DT
          equivalent_NN amount_NN of_IN TGFβ_NNP dissolving_VBG buffer_NN (_( 1_CD mg_NN /_NN ml_NN
          bovine_JJ serum_NN albumine_NN in_IN 4_CD mM_NN HCl_NNP )_) ._. Cells_NNP were_VBD lysed_JJ and_CC
          assayed_JJ for_IN luciferase_NN activity_NN as_IN described_VBN in_IN
          Blumenthal_NNP et_CC al_NN [_NN 20_CD ]_NN ._. For_IN calculation_NN of_IN relative_JJ
          promoter_NN activity_NN ,_, luciferase_NN activity_NN was_VBD normalized_JJ
          against_IN β-galactosidase_JJ activity_NN ._.
        
        
          Preparation_NNP of_IN nuclear_JJ and_CC whole_JJ cell_NN
          extracts_NNS
          Nuclear_JJ extracts_NNS were_VBD obtained_VBN as_IN described_VBN elsewhere_RB
          [_NN 19_CD ]_NN ._. Briefly_NNP ,_, detached_VBN cells_NNS were_VBD resuspended_JJ in_IN
          buffer_NN A_DT (_( 10_CD mM_NN Hepes_NNP pH_NN 7_CD ._. 9_CD ,_, 10_CD mM_NN KCl_NNP ,_, 0_CD ._. 1_CD mM_NN EDTA_NNP ,_, 0_CD ._. 1_CD
          mM_NN EGTA_NNP ,_, 1_CD mM_NN dithiothreitol_NN ,_, 0_CD ._. 5_CD mM_NN phenylmethylsulfonyl_NN
          fluoride_NN )_) and_CC cells_NNS were_VBD lysed_JJ with_IN Nonidet_NNP P-_NNP 40_CD ._. After_IN
          centrifugation_NN at_IN 13000_CD rpm_NN for_IN 1_CD min_NN ,_, nuclei_NN were_VBD
          extracted_VBN by_IN addition_NN of_IN buffer_NN C_NNP (_( 20_CD mM_NN Hepes_NNP pH_NN 7_CD ._. 9_CD ,_,
          0_CD ._. 4_CD M_NNP NaCl_NNP ,_, 1_CD mM_NN EDTA_NNP ,_, 1_CD mM_NN EGTA_NNP ,_, 1_CD mM_NN dithiothreitol_NN ,_,
          0_CD ._. 5_CD mM_NN phenylmethylsulfonyl_NN fluoride_NN )_) ._. Whole_JJ cell_NN
          extraction_NN was_VBD performed_VBN by_IN lysis_NNS of_IN cells_NNS in_IN 250_CD mM_NN
          Tris-_NNP Cl_NNP pH_NN 7_CD ._. 5_CD ,_, three_CD cycles_NNS of_IN freezing_NN and_CC thawing_VBG and_CC
          a_DT subsequent_JJ centrifugation_NN step_NN for_IN 5_CD min_NN at_IN 13_CD ,_, 000_CD rpm_NN
          at_IN 4_CD °_NN C_NNP ._. Total_JJ protein_NN amount_NN in_IN the_DT extracts_NNS was_VBD
          determined_VBN using_VBG the_DT Bio-_NNP Rad_NNP Bradford_NNP reagent_NN ._.
        
        
          Western_NNP Blot_NNP Analysis_NNP
          Cell_NNP extracts_NNS were_VBD analysed_JJ by_IN Western_NNP Blotting_NNP
          analysis_NN as_IN reported_VBN previously_RB [_NN 19_CD ]_NN ._. Mouse_NNP anti-_NN Smad_NNP 3_CD
          (_( H-_NNP 2_LS )_) and_CC rabbit_NN anti-_NN PKC_NNP alpha_NN (_( C-_NNP 20_CD )_) were_VBD purchased_VBN
          from_IN Santa_NNP Cruz_NNP Biotechnology_NNP and_CC diluted_VBN 1_CD :_: 1000_CD ._.
          Visualization_NNP of_IN protein_NN bands_NNS was_VBD carried_VBN out_IN using_VBG
          anti-_NN IgG_NNP horseradish_NN peroxidase_NN and_CC ECL_NNP plus_CC reagents_NNS
          from_IN Amersham_NNP Pharmacia_NNP Biotech_NNP ._.
        
        
          Quantitative_NNP Real-_NNP Time_NNP RT-PCR_NNP
          Isolation_NNP of_IN total_JJ RNA_NNP and_CC synthesis_NN of_IN cDNA_NN were_VBD
          performed_VBN as_RB previously_RB described_VBD [_NN 19_CD ]_NN ._. RT-PCR_NNP
          reactions_NNS of_IN cDNAs_NNS were_VBD conducted_VBN in_IN a_DT total_JJ volume_NN of_IN 15_CD
          μl_NN with_IN 2_CD ×_NN Taqman_NNP Master_NNP Mix_NNP (_( Applied_NNP Biosystems_NNP )_) and_CC
          primers_NNS at_IN optimized_JJ concentrations_NNS ._. Thermal_JJ cycler_NN
          parameters_NNS included_VBD 2_CD min_NN at_IN 50_CD °_NN C_NNP ,_, 10_CD min_NN at_IN 95_CD °_NN C_NNP ,_, and_CC 40_CD
          cycles_NNS involving_VBG denaturation_NN at_IN 95_CD °_NN C_NNP for_IN 15_CD s_VBZ and_CC
          annealing_VBG /_NN extension_NN at_IN 60_CD °_NN C_NNP for_IN 1_CD min_NN ._. Relative_NNP
          quantitation_NN of_IN gene_NN expression_NN was_VBD determined_VBN using_VBG the_DT
          comparative_JJ C_NNP 
          T_NN method_NN following_VBG the_DT manufacturers_NNS
          guidlines_NNS ._. To_TO determine_VB the_DT relative_JJ RNA_NNP levels_NNS of_IN a_DT
          particular_JJ gene_NN ,_, each_DT C_NNP 
          T_NN value_NN was_VBD normalized_JJ against_IN the_DT C_NNP 
          T_NN value_NN of_IN a_DT reference_NN RNA_NNP (_( 18_CD S_NNP rRNA_NN )_) ._.
          The_DT following_VBG primers_NNS were_VBD used_VBN :_:
          
          Ets-_NNP 1_CD :_: forward_RB 5_CD '_POS CGTACGTCCCCCACTCCT_NNP
          3_CD '_''
          reverse_VB 5_CD '_POS TCCCATAGCAATGTCTAATTAATCTGG_NNP 3_CD '_''
          
          Ets-_NNP 2_CD forward_RB 5_CD '_POS
          TTTCTCATGACTCCGCCAACT_NNP 3_CD '_''
          reverse_VB 5_CD '_POS GGCTTGACTCATCACAGCCTT_NNP 3_CD '_''
          
          Ese-_NNP 1_CD /_NN Esx_NNP forward_RB 5_CD '_POS
          CAGGGCAGCTTGGAAGAG_NNP 3_CD '_''
          reverse_VB 5_CD '_POS AAAAGCTTCTTGAAAGGAGACTTCTGT_NNP 3_CD '_''
          
          PTHrP_NNP Exon_NNP 2_CD forward_RB 5_CD '_POS
          AGGAGGCGGTTAGCCCTG_NNP 3_CD '_''
          reverse_VB 5_CD '_POS TCCCATAGCAATGTCTAATTAATCTGG_NNP 3_CD '_''
          
          c-myc_JJ forward_RB 5_CD '_POS GTGCCACGTCTCCACACATC_NNP
          3_CD '_''
          reverse_VB 5_CD '_POS GCAGCAGGATAGTCCTTCCG_NNP 3_CD '_''
          
          Smad_NNP 7_CD forward_RB 5_CD '_POS AAGGTGCGGAGCAAAAT_NNP
          3_CD '_''
          reverse_VB 5_CD '_POS TGTACACCCACACACCATCCA_NNP 3_CD '_''
          
          uPA_NN forward_RB 5_CD '_POS CTGCAGGAACCCAGACAACC_NNP
          3_CD '_''
          reverse_VB 5_CD '_POS GGACAAGCAGCTTTAGGCCC_NNP 3_CD '_''
          
          PAI-_NNP 1_CD forward_RB 5_CD '_POS
          GGCCATGGAACAAGGATGAGA_NNP 3_CD '_''
          reverse_VB 5_CD '_POS GACCAGCTTCAGATCCCGCT_NNP 3_CD '_''
          
          18_CD S_NNP rRNA_NN forward_RB 5_CD '_POS
          CGGCTACCACATCCAAGGAA_NNP 3_CD '_''
          reverse_VB 5_CD '_POS GCTGGAATTACCGCGGCT_NNP 3_CD '_''
        
      
      
        Authors_NNP '_'' contributions_NNS
        Author_NN 1_CD (_( RKL_NNP )_) carried_VBD out_RP the_DT experiments_NNS ._. Author_NN 1_CD
        (_( RKL_NNP )_) and_CC Author_NN 3_CD (_( JD_NNP )_) drafted_VBD the_DT manuscript_NN ._. Authors_NNP 1_CD
        (_( RKL_NNP )_) and_CC Author_NN 3_CD (_( JD_NNP )_) have_VBP conceived_VBN and_CC coordinated_VBN the_DT
        study_NN ._. Author_NN 2_CD (_( AN_DT )_) participitated_JJ in_IN coordination_NN ._. All_DT
        authors_NNS read_VBP and_CC approved_VBD the_DT final_JJ manuscript_NN ._.
      
    
  
